insights_auto
Why is AKTX down 7,49%?
Dive Deeperchevron_right
AKTX:NASDAQ
Akari Therapeutics PLC
US$7,90
arrow_downward
-7,49%(-0,64) 1D
13 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AKTX...
Open
US$8,33
High
US$8,70
Low
US$7,90
Mkt. cap
18,05 ລ້ານ
Avg. vol.
71,58 ພັນ
Volume
18,52 ພັນ
52-wk high
US$39,64
52-wk low
US$3,02
EPS
US$-330,40
Beta
1,43
Shares outstanding
1,14 ລ້ານ
No. of employees
5
Open
US$8,33
High
US$8,70
Low
US$7,90
Mkt. cap
18,05 ລ້ານ
Avg. vol.
71,58 ພັນ
Volume
18,52 ພັນ
52-wk high
US$39,64
52-wk low
US$3,02
EPS
US$-330,40
Beta
1,43
Shares outstanding
1,14 ລ້ານ
No. of employees
5
News stories
From web sources and news partners
www.marketscreener.com
·
3 ຊົ່ວໂມງກ່ອນ
Akari Therapeutics, Plc Announces Appointment of Vatnak Vat-Ho as Chief Business Officer
Investing.com Canada
·
9 ຊົ່ວໂມງກ່ອນ
Akari Therapeutics names Vatnak Vat-Ho as chief business officer By Investing.com
The Manila Times
·
9 ຊົ່ວໂມງກ່ອນ
Akari Therapeutics Appoints Accomplished Oncology and ADC Deal Executive Vatnak Vat-Ho as Chief Business Officer to Drive Strategic Growth and Partnering
StreetInsider
·
10 ຊົ່ວໂມງກ່ອນ
Akari Therapeutics names Vatnak Vat-Ho as chief business officer
About Akari Therapeutics PLC